Expression of Human Recombinant Plasminogen Activators Enhances Invasion and Experimental Metastasis of H-ras-Transformed NIH 3T3 Cells

LITERATURE CITED

• Albini, A., Y. Iwamoto, H. K. Kleinman, G. H. Martin, S. A. Aaronson, J. M. Kozlowski, and R. W. McEwan. 1987. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47:3239–3245.
   PubMed Web of Science ®Google Scholar
• Bernstein, S. C., and R. A. Weinberg. 1985. Expression of the metastatic phenotype in cells transfected with human metastatic tumor DNA. Proc. Natl. Acad. Sci. USA 82:1726–1730.
   PubMed Web of Science ®Google Scholar
• Bradford, M. M.. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248–254.
   PubMed Web of Science ®Google Scholar
• Bradley, M. O., A. R. Kraynak, R. D. Storer, and J. B. Gibbs. 1986. Experimental metastasis in nude mice of NIH/3T3 cells containing various ras genes. Proc. Natl. Acad. Sci. USA 83:5277–5281.
   PubMed Web of Science ®Google Scholar
• Camiolo, S. M., G. Markus, L. S. Englander, M. R. Suita, G. H. Hobika, and S. Kohgen. Plasminogen activator content and secretion in explants of neoplastic and benign tumor prostate tissue. Cancer Res. 44:311–318.
   PubMedGoogle Scholar
• Carlsen, S. A., I. A. Ramshaw, and R. C. Warrington. 1984. Involvement of plasminogen activator production with tumor metastasis in rat model. Cancer Res. 44:3012–3016.
   PubMedGoogle Scholar
• Caruthers, M. H.. 1982. p. 71. In H. G. Gassen, and J. A. Lang (ed.), Chemical and enzymatic synthesis of gene fragments: laboratory manual, p. 71–80. Verlag-Chimie, Weinheim, Federal Republic of Germany.
   Google Scholar
• Dano, K., P. A. Andreasen, J. Grondahl-Hansen, B. P. Kristensen, L. S. Nielsen, and L. Skriver. 1985. Plasminogen activators, tissue degradation and cancer. Adv. Cancer Res. 44:139–266.
   PubMed Web of Science ®Google Scholar
• Eisenbach, L., S. Segal, and M. Feldman. 1985. Proteolytic enzymes in tumor metastasis. I. Plasminogen activator in clones of Lewis lung carcinoma and T10 sarcoma. J. Natl. Cancer Inst. 74:77–85.
   PubMedGoogle Scholar
• Ellis, R. W., D. Defeo, J. M. Maryak, H. A. Young, T. Y. Shih, E. H. Chang, D. R. Lowy, and E. M. Scolnick. 1980. Dual evolutionary origin for the rat genetic sequences of Harvey murine sarcoma virus. J. Virol. 36:408–420.
   PubMed Web of Science ®Google Scholar
• Engvall, E., and E. Rouslahti. 1977. Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int. J. Cancer 20:1–5.
   PubMed Web of Science ®Google Scholar
• Fidler, I. J.. 1978. General considerations for studies of experimental cancer metastasis. Methods Cancer Res. 15:399–439.
   Google Scholar
• Fidler, I. J., D. M. Gersten, and I. R. Hart. 1978. The biology of cancer invasion and metastasis. Adv. Cancer Res. 28:149–250.
   PubMedGoogle Scholar
• Giraldi, T., G. Sava, L. Perissin, and S. Zorzet. 1985. Proteinases and proteinase inhibition by cytotoxic and antimetastatic drugs in transplantable solid metastasizing tumors in mice. Anticancer Res. 5:355–360.
   PubMedGoogle Scholar
• Graham, F. L., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456–467.
   PubMed Web of Science ®Google Scholar
• Greig, R. G., T. P. Koestler, D. L. Trainer, S. P. Corwin, L. Miles, T. Kline, R. Sweet, S. Yokoyama, and G. Poste. 1985. Tumorigenic and metastatic properties of “normal” and ras-transfected NIH/3T3 cells. Proc. Natl. Acad. Sci. USA 82:3698–3701.
   PubMed Web of Science ®Google Scholar
• Gunzler, W. A., G. J. Steffens, F. Otting, S.-M. A. Kim, E. Frankus, and L. Flohe. 1982. The primary structure of high molecular mass urokinase from human urine. Hoppe-Zeyler's Z. Physiol. Chem. 363:1155–1165.
   PubMedGoogle Scholar
• Hagmar, B., W. Ryd, and L. J. Erkell. 1983. Methods in metastatic research. Invasion Metastasis 3:1–21.
   PubMedGoogle Scholar
• Hanna, N.. 1980. Expression of metastatic potential of tumor cells in young nude mice is correlated with low levels of NK cell-mediated cytotoxicity. Int. J. Cancer 26:675–680.
   PubMed Web of Science ®Google Scholar
• Hearing, V. J., L. W. Law, A. Corti, E. Appella, and F. Blasi. 1988. Modulation of metastatic potential by cell surface urokinase of murine melanoma cells. Cancer Res. 48:1270–1278.
   PubMed Web of Science ®Google Scholar
• Huynh, T. Y., R. A. Young, and R. W. Davis. 1984. Constructing and screening cDNA libraries in λgt10 and λgt11, p. 499. In D. Glover (ed.), DNA cloning: a practical approach. IRL Press, New York.
   Google Scholar
• Kirchheimer, J. C., H. Pfluger, P. Ritschl, G. Hienert, and B. R. Binder. 1985. Plasminogen activator activity in bone metastasis of prostatic carcinomas as compared to primary tumors. Invasion Metastasis 5:344–355.
   PubMedGoogle Scholar
• Laub, O., L. B. Rall, M. Truett, Y. Shaul, D. N. Standring, P. Valenzuela, and W. J. Rutter. 1983. Synthesis of hepatitis B surface antigen in mammalian cells: expression of the entire gene and the coding region. J. Virol. 48:271–280.
   PubMedGoogle Scholar
• Liotta, L. A.. 1986. Tumor invasion and metastasis—role of the extracellular matrix: Rhoads Memorial Award Lecture. Cancer Res. 46:1–7.
   PubMed Web of Science ®Google Scholar
• Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
   Google Scholar
• Markus, G.. 1984. The role of hemostasis and fibrinolysis in the metastatic spread of cancer. Semin. Thromb. Hemostasis 10:61–70.
   PubMedGoogle Scholar
• Markus, G., S. M. Camiolio, S. Kohga, J. M. Madeja, and A. Mittelman. 1983. Plasminogen activator secretion of human tumors in short-term organ culture, including a comparison of primary and metastatic colon tumors. Cancer Res. 43:5517–5525.
   PubMed Web of Science ®Google Scholar
• Maxam, A., and W. Gilbert. 1980. Sequencing with base-specific chemical cleavage. Methods Enzymol. 65:499–560.
   PubMedGoogle Scholar
• Menzel, J., and W. Borth. 1983. Influence of plasma fibronectin on collagen cleavage by collagenase. Collagen Related Res. 3:217–230.
   PubMedGoogle Scholar
• Mignatti, P., E. Robbins, and D. B. Rifkin. 1986. Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell 47:487–498.
   PubMed Web of Science ®Google Scholar
• Miskin, R., and H. Soreq. 1981. Sensitive autoradiographic quantification of electrophoretically separated proteases. Anal. Biochem. 118:252–258.
   PubMedGoogle Scholar
• Mulligan, R. C., and P. Berg. 1981. Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyl-transferase. Proc. Natl. Acad. Sci. USA 78:2072–2076.
   PubMed Web of Science ®Google Scholar
• Mullins, D. E., and S. T. Rohrlich. 1983. The role of proteinases in cellular invasiveness. Biochim. Biophys. Acta 695:177–214.
   PubMed Web of Science ®Google Scholar
• Nicolson, G. L.. 1982. Cancer metastasis. Organ colonization and the cell-surface properties of malignant cells. Biochim. Biophys. Acta 695:113–176.
   PubMed Web of Science ®Google Scholar
• Nilsson, B., M. Uhlen, S. Josephson, S. Gatenbeck, and L. Philipson. 1983. An improved positive selection plasmid vector constructed by oligonucleotide mediated mutagenesis. Nucleic Acids Res. 11:8019–8030.
   PubMedGoogle Scholar
• O'Grady, P., H. R. Lijnen, and M. J. Duffy. 1985. Multiple forms of plasminogen activator in human breast tumors. Cancer Res. 45:6216–6218.
   PubMed Web of Science ®Google Scholar
• Ossowski, L.. 1988. Plasminogen activator dependent pathways in the dissemination of human tumor cells in the chick embryo. Cell 52:321–328.
   PubMedGoogle Scholar
• Ossowski, L., and E. Reich. 1983. Antibodies to plasminogen activator inhibit human tumor metastasis. Cell 35:611–619.
   PubMed Web of Science ®Google Scholar
• Pennica, D., W. E. Holmes, W. J. Kohr, R. N. Harkons, G. A. Vehar, C. A. Ward, W. F. Bennett, E. Yelverton, P. H. Seeburg, H. L. Heyneker, D. V. Goeddel, and D. Collen. 1983. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature 310:214–221.
   Google Scholar
• Ramshaw, I. A., P. Badenoch-Jones, A. Grant, M. Maxted, and C. Claudianus. 1986. Enhanced plasminogen activator production by high metastatic variant cell line of a rat mammary adenocarcinoma. Invasion Metastasis 6:133–144.
   PubMedGoogle Scholar
• Reich, E.. 1978. Activation of plasminogen: a general mechanism for producing localized extracellular proteolysis, p. 155–169. In R. D. Berlin, H. Herrmann, I. H. Lepow, and J. M. Tanzer (ed.), Molecular basis of biological degradation processes. Academic Press, New York.
   Google Scholar
• Reich, R., E. Thompson, Y. Iwamoto, G. R. Martin, J. R. Deason, G. C. Fuller, and R. Miskin. 1987. Effects of inhibitors of plasminogen activator, serine proteinases and collagenase IV on the invasion of basement membrane by metastatic cells in mice and humans. Cancer Res. 48:3307–3312.
   Google Scholar
• Sappino, A.-P., N. Busso, D. Belin, and J.-D. Vassali. 1987. Increase of urokinase-type plasminogen activator gene expression in human lung and breast carcinomas. Cancer Res. 47:4043–4046.
   PubMed Web of Science ®Google Scholar
• Schirrmacher, V.. 1985. Cancer metastasis: experimental approaches, theoretical concepts, and impacts for treatment strategies. Adv. Cancer Res. 43:1–73.
   PubMed Web of Science ®Google Scholar
• Shih, C., and R. A. Weinberg. 1982. Isolation of a transforming sequence from a human bladder carcinoma cell line. Cell 29:161–169.
   PubMed Web of Science ®Google Scholar
• Sistonen, L., J. Keski-Oja, I. Ulmanen, E. Holtta, B.-J. Wikgren, and K. Alitalo. 1987. Dose effect of transfected c-Ha-rasVal 12 oncogene in transformed cell clones. Exp. Cell Res. 168:518–530.
   PubMedGoogle Scholar
• Skriver, L., L.-I. Larsson, V. Keilberg, L. S. Nielsene, P. B. Andresen, P. Kristensen, and K. Dano. 1984. Immunocytochemical localization of urokinase-type plasminogen activator in Lewis lung carcinoma. J. Cell Biol. 99:753–757.
   PubMedGoogle Scholar
• Sloane, B. F., K. V. Honn, J. G. Sadler, W. A. Turner, J. J. Kimpson, and J. D. Taylor. 1982. Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential. Cancer Res. 42:980–986.
   PubMed Web of Science ®Google Scholar
• Soreq, H., and R. Miskin. 1981. Plasminogen activator in the rodent brain. Brain Res. 216:361–374.
   PubMedGoogle Scholar
• Southern, P. J., and P. J. Berg. 1982. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. Mol. Appl. Genet. 1:327–341.
   PubMedGoogle Scholar
• Steffens, G. J., W. A. Gunzler, F. Otting, E. Frankus, and L. Flohe. 1982. The complete amino acid sequence of low molecular mass urokinase from human urine. Hoppe-Zeyler's Z. Physiol. Chem. 363:1043–1058.
   PubMedGoogle Scholar
• Strickland, S., E. Reich, and M. Sherman. 1976. Plasminogen activator in early embryogenesis: enzyme production by trophoblast and parietal endoderm. Cell 9:231–240.
   PubMed Web of Science ®Google Scholar
• Thorgeirsson, U. P., T. Turpeenniemi-Hujanen, J. E. Williams, E. H. Westin, C. A. Heilman, J. E. Talmadge, and L. A. Liotta. 1985. NIH/3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude mice. Mol. Cell. Biol. 5:259–262.
   PubMed Web of Science ®Google Scholar
• Wang, B. S., G. A. McLoughlin, J. P. Richie, and J. A. Mannick. 1979. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines. Cancer Res. 40:288–292.
   Google Scholar
• Wexler, H.. 1966. Accurate identification of experimental pulmonary metastases. J. Natl. Cancer Inst. 36:641–645.
   PubMed Web of Science ®Google Scholar